Th17/IL-17 Axis in HTLV-1-associated myelopathy tropical spastic Paraparesis and multiple sclerosis: novel insights into the immunity during HAMTSP

M Shafiei, SH Mozhgani - Molecular Neurobiology, 2023 - Springer
Human T lymphotropic virus–associated myelopathy/tropical spastic paraparesis
(HTLV/TSP), also known as HTLV-associated myelopathy/tropical spastic paraparesis …

[HTML][HTML] Brazilian protocol for sexually transmitted infections 2020: human T-cell lymphotropic virus (HTLV) infection

C Rosadas, C Brites, D Arakaki-Sanchez… - Revista da Sociedade …, 2021 - SciELO Brasil
This article addresses the Human T-lymphotropic virus (HTLV). This subject comprises the
Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with …

[HTML][HTML] Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: infecção pelo vírus linfotrópico de células T humanas (HTLV)

C Rosadas, C Brites, D Arakaki-Sánchez… - … e Serviços de Saúde, 2021 - SciELO Brasil
O artigo aborda a infecção pelo vírus linfotrópico de células T humanas (human T
lymphotropic virus, HTLV), tema contemplado no Protocolo Clínico e Diretrizes Terapêuticas …

HIV co-infection in HTLV-1 carriers in Spain

C de Mendoza, E Caballero, A Aguilera, R Benito… - Virus research, 2019 - Elsevier
Background Human retroviruses HIV and HTLV share transmission routes. HIV widely
spread in Spain during the 80 s through injection drug use and sex, and nowadays HIV rates …

Hiv pre-immunization and immunotherapy

CD Pauza - US Patent 11,980,663, 2024 - Google Patents
The present invention relates generally to immunization and immunotherapy for the
treatment or prevention of HIV. In particular, the methods relate to in vivo and ex vivo …

Biomarkers in a Cohort of HIV-Infected Patients Single-or Co-Infected with HTLV-1, HTLV-2, and/or HCV: A Cross-Sectional, Observational Study

A Caterino-de-Araujo, KR Campos, LMS Oliveira… - Viruses, 2022 - mdpi.com
HIV, HTLV-1/-2, and HCV share routes of transmission, and such virus co-infections could
account for worse outcomes of associated diseases. Measuring cytokines/chemokines, CD4 …

Method of producing cells resistant to HIV infection

CD Pauza, H Li, T Lahusen - US Patent 10,888,613, 2021 - Google Patents
2018-09-14 Assigned to AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
reassignment AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. ASSIGNMENT …

The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C …

KR Campos, FA Alves, MF Lemos… - PLoS neglected …, 2020 - journals.plos.org
Background The WHO established targets for 2030 to globally reduce new viral hepatitis B
and C infections by 90% and deaths by 65% and recommends searching for coinfections …

Methods and compositions for the activation of gamma-delta T-cells

CD Pauza, H Li, T Lahusen, ML Liou - US Patent 11,519,006, 2022 - Google Patents
Related US Application Data (63) Continuation of application No. 16/182,443, filed on Nov.
6, 2018, now Pat. No. 10.428. 350, which is a continuation of application No. 16/008991 …

Methods and compositions for the activation of gamma-delta T-cells

CD Pauza, H Li, T Lahusen, ML Liou - US Patent 10,772,905, 2020 - Google Patents
US10772905B2 - Methods and compositions for the activation of gamma-delta T-cells -
Google Patents US10772905B2 - Methods and compositions for the activation of gamma-delta …